Ian Read bags $19.5 million, taking a big pay cut for his swan song as Pfizer CEO and leaving the pharma giant at a crossroads

Ian Read bags $19.5 million, taking a big pay cut for his swan song as Pfizer CEO and leaving the pharma giant at a crossroads

Source: 
Endpoints
snippet: 

Ian Read passed the CEO title on to his hand picked successor Albert Bourla at the beginning of this year, but not before one last big haul of executive compensation. His overall number came down substantially from 2017, largely due to a big drop in the stock option column, but he still scored $19.5 million for 2018 compensation.